如何CBX蛋白调节正常和白血病血细胞
Anne P de Groot1,2, Gerald de Haan1,2,3
1European Research Institute for Biology of Ageing (ERIBA), University Medical Center Groningen (UMCG), The Netherlands.
FEBS letters
|March 1, 2024
概括
聚合体抑制复合体1 (PRC1) 中的染色体 (CBX) 蛋白调节造血干细胞 (HSC) 的自我更新. 不同的CBX蛋白质影响HSC命运,衰老和白血病,提供治疗点.
科学领域:
- 血液学 血液学 血液学
- 表观遗传学 在表观遗传学中,表观遗传学是指表观遗传学.
- 分子生物学分子生物学
背景情况:
- 造血干细胞 (HSC) 的自我更新对于血液形成至关重要,并由表观遗传机制调节.
- 多胞体抑制综合体1 (PRC1) 在抑制分化基因,维持高细胞功能方面发挥着关键作用.
- PRC1的特定染色盒 (CBX) 蛋白子单元影响HSC命运决策.
研究的目的:
- 审查染色盒 (CBX) 蛋白在调节造血干细胞 (HSC) 命运中的多样性作用.
- 探索CBX蛋白质如何促进与年龄相关的变化和HSC中的瘤性转变.
- 讨论针对白血病中CBX蛋白的治疗策略.
主要方法:
- 关于PRC1,CBX蛋白和HSC生物学研究的文献综述.
- 对CBX蛋白的表观遗传和非表观遗传功能的分析.
- 检查CBX蛋白对HSC自我更新,衰老和白血病发生的影响.
主要成果:
- 在PRC1中,不同的CBX蛋白 (CBX2,CBX4,CBX6,CBX7,CBX8) 导致不同的HSC命运结果.
- CBX 蛋白质影响与年龄相关的 HSC 变化,并促进瘤性途径.
- CBX2,CBX7和CBX8都与增强白血病进展有关.
- CBX蛋白的正规表观遗传和替代非表观遗传相互作用都与此相关.
结论:
- CBX蛋白质是HSC命运的关键调节者,特定的子单元影响自我更新,衰老和疾病.
- 针对瘤性CBX蛋白的表观遗传功能,为白血病提供了一个有前途的治疗途径.
- 需要进一步的研究来阐明细胞质CBX蛋白在血细胞发育和疾病中的非表观遗传作用.
相关概念视频
Regulation of Hematopoietic Stem Cells
3.2K
All blood and immune cells are produced from the multipotent hematopoietic stem cells (HSCs) by the process of hematopoiesis. However, they all have a limited life span. In addition, many are depleted in immune surveillance or combatting an injury or infection. This makes blood one of the most regenerative tissues. Hematopoiesis helps replenish these blood and immune cells, restoring the body's normal functioning. However, overproduction of blood and immune cells can make them cancerous or...
3.2K
Differentiation of Common Myeloid Progenitor Cells
3.2K
Common myeloid progenitors (CMPs) are oligopotent cells that can differentiate into granulocytes and macrophages. Granulocytes and macrophages are essential for protecting the body against bacterial, viral, or fungal infections. They migrate from the bone marrow into the circulating blood to reach specific tissue sites where they differentiate and help in immune surveillance. However, they survive only for a few days and must be continuously made available to the organism to maintain a robust...
3.2K
Receptor Downregulation in MVBs
2.1K
Multivesicular bodies (MVBs) are mature endosomes that sort ubiquitinated proteins and then fuse with lysosomes to degrade the sorted proteins. Epidermal growth factor (EGF) and its receptor (EGFR) form a complex that can be internalized through endocytosis, sorted into an MVB, and later degraded.
The EGFR can initiate signaling pathways that lead to cell proliferation, migration, and differentiation. Overexpression of EGFR stimulates cells to proliferate. Excessive EGFR...
The EGFR can initiate signaling pathways that lead to cell proliferation, migration, and differentiation. Overexpression of EGFR stimulates cells to proliferate. Excessive EGFR...
2.1K
Role of Hematopoietic Growth Factors
1.4K
Hematopoietic growth factors are molecules that regulate the differentiation rate of hematopoietic stem cells (HSCs). Erythropoietin (EPO), primarily produced by the kidneys, plays a crucial role in erythrocyte production. When oxygen levels in the blood are low, EPO is released into the bloodstream, reaching the bone marrow, where it stimulates HSCs to differentiate and mature into erythrocytes, which are vital for oxygen transport.
Thrombopoietin (TPO), mainly released by the liver,...
Thrombopoietin (TPO), mainly released by the liver,...
1.4K
Negative Regulator Molecules
35.4K
Positive regulators allow a cell to advance through cell cycle checkpoints. Negative regulators have an equally important role as they terminate a cell’s progression through the cell cycle—or pause it—until the cell meets specific criteria.
35.4K
Disorders of Leukocytes
950
Leukocyte disorders can lead to either leukopenia, characterized by an abnormally low leukocyte count, or leukocytosis, marked by a very high leukocyte number.
Leukopenia may result from bone marrow disorders, autoimmune diseases, and infectious diseases. For example, conditions such as multiple myeloma and aplastic anemia can impair the bone marrow's ability to produce adequate leukocytes. Similarly, autoimmune diseases like lupus and viral infections such as HIV can prompt the immune...
Leukopenia may result from bone marrow disorders, autoimmune diseases, and infectious diseases. For example, conditions such as multiple myeloma and aplastic anemia can impair the bone marrow's ability to produce adequate leukocytes. Similarly, autoimmune diseases like lupus and viral infections such as HIV can prompt the immune...
950


